查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1946633

2026年全球核酸增幅檢查市場報告

Nucleic Acid Amplification Testing Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，核酸增幅檢查市場發展迅速，預計將從2025年的110.3億美元成長到2026年的127億美元，複合年成長率達15.2%。過去幾年成長要素包括感染疾病的爆發、臨床檢查室的擴張、PCR技術的廣泛應用、公共衛生篩檢計畫的實施以及檢測成本的下降。

預計未來幾年核酸增幅檢查市場將快速成長，到2030年市場規模將達221億美元，複合年成長率（CAGR）為14.8%。預測期內的成長要素包括個人化醫療的進步、對快速診斷的需求、新興市場的擴張、技術的微型化以及新型檢測方法的監管核准。預測期內的主要趨勢包括快速照護現場分子檢測、多重和症候群檢測方案的擴展、等溫擴增技術的日益普及、居家和分散式檢查的成長以及對疾病早期檢測的日益重視。

感染疾病率的不斷上升將進一步推動核酸增幅檢查市場在未來的擴張。感染疾病是由病原體引起的疾病，其傳播途徑包括直接接觸、空氣傳播、受污染的食物和水以及媒介傳播。感染疾病的增加與抗生素抗藥性、氣候變遷、人類行為的改變以及農業實踐的改變密切相關。核酸增幅檢查能夠快速且準確地識別感染疾病病原體，從而支持及時診斷和治療，並有助於控制疾病傳播。例如，根據加拿大公共衛生署（一個政府機構）2023年10月發布的公告，參與的省份和地區在2022-2023流感季報告了4216例與流感相關的住院病例。因此，感染疾病率的不斷上升正在增強對核酸增幅檢查解決方案的需求。

核酸增幅檢查市場的主要企業正致力於開發創新解決方案，例如體外診斷 (IVD) 檢測。例如，IVD 檢測採用符合體外診斷藥物法規 (IVDR) 的核酸擴增技術 (NAT) 對捐血血液中的巨細胞病毒(CMV) 進行篩檢。 IVD 檢測是在實驗室對生物檢體的檢測，用於檢測人體以外的疾病、病症或感染疾病。例如，總部位於德國的 GFE 公司於 2024 年 6 月推出了“PoET CMV”，這是一種用於快速、準確檢測 CMV 感染的 IVD 檢測方法。此檢測方法具有高靈敏度和特異性，可支持對移植患者和免疫力缺乏患者進行 CMV 的早期診斷和有效監測。透過利用先進的分子技術，此檢測方法可提供快速、可靠的結果，從而支援及時的臨床決策。

目錄

第1章執行摘要

第2章 市場特徵

  • 市場定義和範圍
  • 市場區隔
  • 主要產品和服務概述
  • 全球核酸增幅檢查市場：吸引力評分與分析
  • 成長潛力分析、競爭評估、策略契合度評估、風險狀況評估

第3章 市場供應鏈分析

  • 供應鏈與生態系概述
  • 主要原料、資源和供應商清單
  • 主要經銷商和通路合作夥伴名單
  • 主要最終用戶列表

第4章 全球市場趨勢與策略

  • 關鍵技術和未來趨勢
    • 生物技術、基因組學和精準醫學
    • 人工智慧（AI）和自主人工智慧
    • 數位化、雲端運算、巨量資料、網路安全
    • 工業4.0和智慧製造
    • 物聯網、智慧基礎設施和互聯生態系統
  • 主要趨勢
    • 快速照護現場分子檢測
    • 擴大多重和症候群檢測小組
    • 等溫擴增技術的應用日益廣泛
    • 居家檢測和分散式檢查的成長
    • 人們越來越關注疾病早期檢測

第5章 終端用戶產業市場分析

  • 醫院
  • 診斷檢查室
  • 生技公司
  • 研究所
  • 公共衛生機構

第6章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅的影響、關稅戰和貿易保護主義對供應鏈的影響，以及新冠疫情對市場的影響

第7章 全球策略分析架構、目前市場規模、市場對比及成長率分析

  • 全球核酸增幅檢查市場：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素與限制因素）
  • 全球核酸增幅檢查市場規模、對比及成長率分析
  • 全球核酸增幅檢查市場表現：規模與成長，2020-2025年
  • 全球核酸增幅檢查市場預測：規模與成長，2025-2030年，2035年預測

第8章 全球潛在市場規模（TAM）

第9章 市場細分

  • 按類型
  • 標靶放大系統、探針放大系統、訊號放大系統
  • 透過擴增方法
  • 耗材、設備或系統
  • 透過技術
  • 聚合酵素鏈鎖反應（PCR）檢測、恒溫核酸增幅技術（INAAT）檢測與連接酶鍊式反應（LCR）檢測
  • 透過使用
  • 傳染病檢查、腫瘤檢測、遺傳和粒線體疾病檢測以及其他應用
  • 按最終用途
  • 醫院、診斷檢查室、生物技術公司和其他終端用戶
  • 按類型細分：標靶擴增系統
  • 聚合酵素鏈鎖反應（PCR）、即時PCR（qPCR）、逆轉錄聚合酵素鏈鎖反應（RT-PCR）、巢式PCR、多重PCR、恒溫環型核酸擴增（LAMP）
  • 按類型細分：探針放大系統
  • 核酸序列擴增（NASBA）、雜合反應擴增、支鏈擴增（BCA）、鏈置換擴增（SDA）
  • 按類型細分：訊號放大系統
  • 酵素訊號放大、螢光訊號放大、化學冷光訊號放大、電化學訊號放大、磁性顆粒訊號放大

第10章 區域與國家分析

  • 全球核酸增幅檢查市場：依地區分類，結果及預測，2020-2025年、2025-2030年預測、2035年預測
  • 全球核酸增幅檢查市場：依國家/地區、效能和預測分類，2020-2025年、2025-2030年預測、2035年預測

第11章 亞太市場

第12章：中國市場

第13章 印度市場

第14章 日本市場

第15章：澳洲市場

第16章 印尼市場

第17章 韓國市場

第18章 台灣市場

第19章 東南亞市場

第20章：西歐市場

第21章英國市場

第22章 德國市場

第23章：法國市場

第24章：義大利市場

第25章：西班牙市場

第26章 東歐市場

第27章：俄羅斯市場

第28章 北美市場

第29章：美國市場

第30章：加拿大市場

第31章 南美洲市場

第32章：巴西市場

第33章 中東市場

第34章：非洲市場

第35章 市場監理與投資環境

第36章：競爭格局與公司概況

  • 核酸增幅檢查市場：競爭格局及市場佔有率（2024年）
  • 核酸增幅檢查市場：公司評估矩陣
  • 核酸增幅檢查市場：公司概況
    • F. Hoffmann-La Roche Ltd.
    • Thermo Fisher Scientific Inc.
    • Abbott Laboratories
    • Merck KGaA
    • Siemens Healthineers

第37章：其他領先和創新企業

  • Becton, Dickinson and Company, Laboratory Corporation of America Holdings, Quest Diagnostics, Agilent Technologies Inc., Grifols SA, Hologic Inc., bioMerieux SA, QuidelOrtho Corporation, Bio-Rad Laboratories Inc., Cepheid Inc., GenScript Biotech Corporation, ARUP Laboratories, BGI Group, Promega Corporation, Meridian Bioscience Inc.

第38章 全球市場競爭基準分析與儀錶板

第39章 重大併購

第40章：高潛力市場國家、細分市場與策略

  • 2030年核酸增幅檢查市場：提供新機會的國家
  • 核酸增幅檢查市場展望（2030）：新興細分市場蘊藏新的機會
  • 核酸增幅檢查市場2030年：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第41章附錄

簡介目錄
Product Code: ME4MNAAT02_G26Q1

Nucleic acid amplification testing (NAAT) is a molecular technique that detects and amplifies DNA or RNA in samples, enabling early pathogen detection and advancing research into genetic diseases and targeted therapies.

The primary types of nucleic acid amplification testing include target amplification systems, probe amplification systems, and signal amplification systems. Target amplification systems are methods used to amplify specific nucleic acid sequences within a sample and are essential for improving sensitivity and precision in nucleic acid amplification testing (NAAT). The product categories include consumables and instruments or systems incorporating technologies such as polymerase chain reaction (PCR) tests, isothermal nucleic acid amplification technology (INAAT) tests, and ligase chain reaction (LCR) tests. These are applied in areas including infectious disease testing, oncology diagnostics, genetic and mitochondrial disease testing, and others and are used by end users such as hospitals, diagnostic laboratories, biotechnology companies, and others.

Tariffs are impacting the nucleic acid amplification testing market by increasing costs of imported reagents, instruments, and precision components used in PCR and isothermal systems. Consumables and instruments segments are most affected, particularly in Asia-Pacific and North America where global supply chains are highly interconnected. Higher costs have slowed procurement cycles for hospitals and diagnostic laboratories. However, tariffs are encouraging local manufacturing, regional sourcing, and domestic capacity expansion, supporting long-term supply chain resilience.

The nucleic acid amplification testing market research report is one of a series of new reports from The Business Research Company that provides nucleic acid amplification testing market statistics, including nucleic acid amplification testing industry global market size, regional shares, competitors with a nucleic acid amplification testing market share, detailed nucleic acid amplification testing market segments, market trends and opportunities, and any further data you may need to thrive in the nucleic acid amplification testing industry. This nucleic acid amplification testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The nucleic acid amplification testing market size has grown rapidly in recent years. It will grow from $11.03 billion in 2025 to $12.7 billion in 2026 at a compound annual growth rate (CAGR) of 15.2%. The growth in the historic period can be attributed to infectious disease outbreaks, expansion of clinical laboratories, PCR technology adoption, public health screening programs, declining assay costs.

The nucleic acid amplification testing market size is expected to see rapid growth in the next few years. It will grow to $22.1 billion in 2030 at a compound annual growth rate (CAGR) of 14.8%. The growth in the forecast period can be attributed to personalized medicine growth, demand for rapid diagnostics, expansion in emerging markets, technological miniaturization, regulatory approvals for novel assays. Major trends in the forecast period include rapid point-of-care molecular testing, expansion of multiplex and syndromic panels, rising adoption of isothermal amplification techniques, growth in home-based and decentralized testing, increasing focus on early disease detection.

The increasing incidence of infectious diseases is increasingly supporting the expansion of the nucleic acid amplification testing market going forward. Infectious diseases are conditions caused by pathogenic organisms that spread through direct contact, airborne transmission, contaminated food or water, or vector-borne pathways. The rise in infectious diseases is associated with antibiotic resistance, climate change, changes in human behavior, and agricultural practices. Nucleic acid amplification testing enables rapid and accurate identification of infectious pathogens, supporting timely diagnosis and treatment while helping limit disease transmission. For example, in October 2023, according to the Public Health Agency of Canada, a government agency, participating provinces and territories reported 4,216 influenza-related hospitalizations during the 2022-2023 season. Consequently, the growing incidence of infectious diseases is strengthening demand for nucleic acid amplification testing solutions.

Leading companies operating in the nucleic acid amplification testing market are focusing on developing innovative solutions, such as in vitro diagnostics (IVD) assays, to screen donated blood for cytomegalovirus (CMV) using nucleic acid amplification technology (NAT) in compliance with the IVDR. An IVD assay is a laboratory-based test performed on biological samples to detect diseases, conditions, or infections outside the human body. For example, in June 2024, GFE, a Germany-based company, launched PoET CMV, an IVD assay designed for the rapid and accurate detection of CMV infections. The assay offers high sensitivity and specificity, supporting early diagnosis and effective monitoring of CMV in transplant recipients and immunocompromised patients. By leveraging advanced molecular techniques, the test delivers reliable results quickly, enabling timely clinical decision-making.

In July 2024, Roche Holding AG, a Switzerland-based pharmaceutical company, acquired LumiraDx for an undisclosed amount. With this acquisition, Roche aims to expand its diagnostics division by offering a broader range of immunoassay and clinical chemistry tests that provide high-value testing without requiring specialized cold storage. This approach supports use across diverse healthcare settings while improving testing efficiency and patient outcomes, particularly in primary care and underserved regions. LumiraDx is a UK-based provider of nucleic acid amplification testing solutions.

Major companies operating in the nucleic acid amplification testing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Merck KGaA, Siemens Healthineers, Becton Dickinson and Company, Laboratory Corporation of America Holdings, Quest Diagnostics, Agilent Technologies Inc., Grifols S.A., Hologic Inc., bioMerieux SA, QuidelOrtho Corporation, Bio-Rad Laboratories Inc., Cepheid Inc., GenScript Biotech Corporation, ARUP Laboratories, BGI Group, Promega Corporation, Meridian Bioscience Inc., Takara Bio Inc., Eiken Chemical Co. Ltd., New England Biolabs Inc., TwistDx Limited, Bioneer Corporation

North America was the largest region in the nucleic acid amplification testing (NAAT) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the nucleic acid amplification testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the nucleic acid amplification testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The nucleic acid amplification testing (NAAT) market consists of revenue earned by entities by provide services such as genetic disorder screening, environmental testing, infectious disease diagnosis, and pharmacogenomics. The market value includes the value of related goods sold by the service provider or included within the service offering. The nucleic acid amplification testing (NAAT) market also includes sales of reagents, pre-packaged kits, test tubes, pipettes, and plates. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Nucleic Acid Amplification Testing Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses nucleic acid amplification testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for nucleic acid amplification testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The nucleic acid amplification testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Type: Target Amplification Systems; Probe Amplification Systems; Signal Amplification Systems
  • 2) By Amplification Method: Consumables; Instruments Or Systems
  • 3) By Technology: Polymerase Chain Reaction (PCR) Tests; Isothermal Nucleic Acid Amplification Technology (INAAT) Tests; Ligase Chain Reaction (LCR) Tests
  • 4) By Application: Infectious Disease Testing; Oncology Testing; Genetic And Mitochondrial Disease Testing; Other Applications
  • 5) By End-Use: Hospitals; Diagnostic Laboratories; Biotechnology Companies; Other End-Users
  • Subsegments:
  • 1) By Target Amplification Systems: Polymerase Chain Reaction (PCR); Real-Time PCR (qPCR); Reverse Transcription PCR (RT-PCR); Nested PCR; Multiplex PCR; LAMP (Loop-Mediated Isothermal Amplification);
  • 2) By Probe Amplification Systems: Nucleic Acid Sequence-Based Amplification (NASBA); Hybridization-Based Amplification; Branch Chain Amplification (BCA); Strand Displacement Amplification (SDA);
  • 3) By Signal Amplification Systems: Enzyme-Linked Signal Amplification; Fluorescent Signal Amplification; Chemiluminescent Signal Amplification; Electrochemical Signal Amplification; Magnetic Particle-Based Signal Amplification
  • Companies Mentioned: F. Hoffmann-La Roche Ltd.; Thermo Fisher Scientific Inc.; Abbott Laboratories; Merck KGaA; Siemens Healthineers; Becton Dickinson and Company; Laboratory Corporation of America Holdings; Quest Diagnostics; Agilent Technologies Inc.; Grifols S.A.; Hologic Inc.; bioMerieux SA; QuidelOrtho Corporation; Bio-Rad Laboratories Inc.; Cepheid Inc.; GenScript Biotech Corporation; ARUP Laboratories; BGI Group; Promega Corporation; Meridian Bioscience Inc.; Takara Bio Inc.; Eiken Chemical Co. Ltd.; New England Biolabs Inc.; TwistDx Limited; Bioneer Corporation
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Nucleic Acid Amplification Testing Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Nucleic Acid Amplification Testing Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Nucleic Acid Amplification Testing Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Nucleic Acid Amplification Testing Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Artificial Intelligence & Autonomous Intelligence
    • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.4 Industry 4.0 & Intelligent Manufacturing
    • 4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
  • 4.2. Major Trends
    • 4.2.1 Rapid Point-Of-Care Molecular Testing
    • 4.2.2 Expansion Of Multiplex And Syndromic Panels
    • 4.2.3 Rising Adoption Of Isothermal Amplification Techniques
    • 4.2.4 Growth In Home-Based And Decentralized Testing
    • 4.2.5 Increasing Focus On Early Disease Detection

5. Nucleic Acid Amplification Testing Market Analysis Of End Use Industries

  • 5.1 Hospitals
  • 5.2 Diagnostic Laboratories
  • 5.3 Biotechnology Companies
  • 5.4 Research Institutes
  • 5.5 Public Health Agencies

6. Nucleic Acid Amplification Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Nucleic Acid Amplification Testing Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Nucleic Acid Amplification Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Nucleic Acid Amplification Testing Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Nucleic Acid Amplification Testing Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Nucleic Acid Amplification Testing Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Nucleic Acid Amplification Testing Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Nucleic Acid Amplification Testing Market Segmentation

  • 9.1. Global Nucleic Acid Amplification Testing Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Target Amplification Systems, Probe Amplification Systems, Signal Amplification Systems
  • 9.2. Global Nucleic Acid Amplification Testing Market, Segmentation By Amplification Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Consumables, Instruments Or Systems
  • 9.3. Global Nucleic Acid Amplification Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Polymerase Chain Reaction (PCR) Tests, Isothermal Nucleic Acid Amplification Technology (INAAT) Tests, Ligase Chain Reaction (LCR) Tests
  • 9.4. Global Nucleic Acid Amplification Testing Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Infectious Disease Testing, Oncology Testing, Genetic And Mitochondrial Disease Testing, Other Applications
  • 9.5. Global Nucleic Acid Amplification Testing Market, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospitals, Diagnostic Laboratories, Biotechnology Companies, Other End-Users
  • 9.6. Global Nucleic Acid Amplification Testing Market, Sub-Segmentation Of Target Amplification Systems, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Polymerase Chain Reaction (PCR), Real-Time PCR (qPCR), Reverse Transcription PCR (RT-PCR), Nested PCR, Multiplex PCR, LAMP (Loop-Mediated Isothermal Amplification)
  • 9.7. Global Nucleic Acid Amplification Testing Market, Sub-Segmentation Of Probe Amplification Systems, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Nucleic Acid Sequence-Based Amplification (NASBA), Hybridization-Based Amplification, Branch Chain Amplification (BCA), Strand Displacement Amplification (SDA)
  • 9.8. Global Nucleic Acid Amplification Testing Market, Sub-Segmentation Of Signal Amplification Systems, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Enzyme-Linked Signal Amplification, Fluorescent Signal Amplification, Chemiluminescent Signal Amplification, Electrochemical Signal Amplification, Magnetic Particle-Based Signal Amplification

10. Nucleic Acid Amplification Testing Market Regional And Country Analysis

  • 10.1. Global Nucleic Acid Amplification Testing Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Nucleic Acid Amplification Testing Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Nucleic Acid Amplification Testing Market

  • 11.1. Asia-Pacific Nucleic Acid Amplification Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Nucleic Acid Amplification Testing Market, Segmentation By Type, Segmentation By Amplification Method, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Nucleic Acid Amplification Testing Market

  • 12.1. China Nucleic Acid Amplification Testing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Nucleic Acid Amplification Testing Market, Segmentation By Type, Segmentation By Amplification Method, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Nucleic Acid Amplification Testing Market

  • 13.1. India Nucleic Acid Amplification Testing Market, Segmentation By Type, Segmentation By Amplification Method, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Nucleic Acid Amplification Testing Market

  • 14.1. Japan Nucleic Acid Amplification Testing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Nucleic Acid Amplification Testing Market, Segmentation By Type, Segmentation By Amplification Method, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Nucleic Acid Amplification Testing Market

  • 15.1. Australia Nucleic Acid Amplification Testing Market, Segmentation By Type, Segmentation By Amplification Method, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Nucleic Acid Amplification Testing Market

  • 16.1. Indonesia Nucleic Acid Amplification Testing Market, Segmentation By Type, Segmentation By Amplification Method, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Nucleic Acid Amplification Testing Market

  • 17.1. South Korea Nucleic Acid Amplification Testing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Nucleic Acid Amplification Testing Market, Segmentation By Type, Segmentation By Amplification Method, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Nucleic Acid Amplification Testing Market

  • 18.1. Taiwan Nucleic Acid Amplification Testing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Nucleic Acid Amplification Testing Market, Segmentation By Type, Segmentation By Amplification Method, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Nucleic Acid Amplification Testing Market

  • 19.1. South East Asia Nucleic Acid Amplification Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Nucleic Acid Amplification Testing Market, Segmentation By Type, Segmentation By Amplification Method, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Nucleic Acid Amplification Testing Market

  • 20.1. Western Europe Nucleic Acid Amplification Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Nucleic Acid Amplification Testing Market, Segmentation By Type, Segmentation By Amplification Method, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Nucleic Acid Amplification Testing Market

  • 21.1. UK Nucleic Acid Amplification Testing Market, Segmentation By Type, Segmentation By Amplification Method, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Nucleic Acid Amplification Testing Market

  • 22.1. Germany Nucleic Acid Amplification Testing Market, Segmentation By Type, Segmentation By Amplification Method, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Nucleic Acid Amplification Testing Market

  • 23.1. France Nucleic Acid Amplification Testing Market, Segmentation By Type, Segmentation By Amplification Method, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Nucleic Acid Amplification Testing Market

  • 24.1. Italy Nucleic Acid Amplification Testing Market, Segmentation By Type, Segmentation By Amplification Method, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Nucleic Acid Amplification Testing Market

  • 25.1. Spain Nucleic Acid Amplification Testing Market, Segmentation By Type, Segmentation By Amplification Method, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Nucleic Acid Amplification Testing Market

  • 26.1. Eastern Europe Nucleic Acid Amplification Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Nucleic Acid Amplification Testing Market, Segmentation By Type, Segmentation By Amplification Method, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Nucleic Acid Amplification Testing Market

  • 27.1. Russia Nucleic Acid Amplification Testing Market, Segmentation By Type, Segmentation By Amplification Method, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Nucleic Acid Amplification Testing Market

  • 28.1. North America Nucleic Acid Amplification Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Nucleic Acid Amplification Testing Market, Segmentation By Type, Segmentation By Amplification Method, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Nucleic Acid Amplification Testing Market

  • 29.1. USA Nucleic Acid Amplification Testing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Nucleic Acid Amplification Testing Market, Segmentation By Type, Segmentation By Amplification Method, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Nucleic Acid Amplification Testing Market

  • 30.1. Canada Nucleic Acid Amplification Testing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Nucleic Acid Amplification Testing Market, Segmentation By Type, Segmentation By Amplification Method, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Nucleic Acid Amplification Testing Market

  • 31.1. South America Nucleic Acid Amplification Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Nucleic Acid Amplification Testing Market, Segmentation By Type, Segmentation By Amplification Method, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Nucleic Acid Amplification Testing Market

  • 32.1. Brazil Nucleic Acid Amplification Testing Market, Segmentation By Type, Segmentation By Amplification Method, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Nucleic Acid Amplification Testing Market

  • 33.1. Middle East Nucleic Acid Amplification Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Nucleic Acid Amplification Testing Market, Segmentation By Type, Segmentation By Amplification Method, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Nucleic Acid Amplification Testing Market

  • 34.1. Africa Nucleic Acid Amplification Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Nucleic Acid Amplification Testing Market, Segmentation By Type, Segmentation By Amplification Method, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Nucleic Acid Amplification Testing Market Regulatory and Investment Landscape

36. Nucleic Acid Amplification Testing Market Competitive Landscape And Company Profiles

  • 36.1. Nucleic Acid Amplification Testing Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Nucleic Acid Amplification Testing Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Nucleic Acid Amplification Testing Market Company Profiles
    • 36.3.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Siemens Healthineers Overview, Products and Services, Strategy and Financial Analysis

37. Nucleic Acid Amplification Testing Market Other Major And Innovative Companies

  • Becton, Dickinson and Company, Laboratory Corporation of America Holdings, Quest Diagnostics, Agilent Technologies Inc., Grifols S.A., Hologic Inc., bioMerieux SA, QuidelOrtho Corporation, Bio-Rad Laboratories Inc., Cepheid Inc., GenScript Biotech Corporation, ARUP Laboratories, BGI Group, Promega Corporation, Meridian Bioscience Inc.

38. Global Nucleic Acid Amplification Testing Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Nucleic Acid Amplification Testing Market

40. Nucleic Acid Amplification Testing Market High Potential Countries, Segments and Strategies

  • 40.1 Nucleic Acid Amplification Testing Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Nucleic Acid Amplification Testing Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Nucleic Acid Amplification Testing Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer